Online citations, reference lists, and bibliographies.
← Back to Search

5β-Cholanic Acid/Glycol Chitosan Self-Assembled Nanoparticles (5β-CHA/GC-NPs) For Enhancing The Absorption Of FDs And Insulin By Rat Intestinal Membranes

Chengyun Yan, J. Gu, Yuguang Lv, Weiguo Shi, Z. Huang, Ying Liao
Published 2018 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The absorption-enhancing effects of glycol chitosan modified by 5β-cholanic acid nanoparticles (5β-CHA/GC-NPs) on a drug with poor absorption in the intestine were studied by the method of in situ closed loop. We chose fluorescein isothiocyanate-labeled dextrans (FDs) and insulin as the model drugs. 5β-CHA/GC-NPs loaded to different drugs were prepared by the dialysis method, and the physicochemical characteristics and in vitro release profiles of nanoparticles were also estimated. The results showed that 5β-CHA/GC-NPs markedly increased the absorption of insulin and FDs in the jejunum, ileum, and colon. The ratios of absorption for all the drugs in the jejunum were higher than those in the ileum and colon. In addition, the enhancing effect of 5β-CHA/GC-NPs for the absorption of FDs from the jejunum was decreased with increasing molecular weights. In the toxicity test, 5β-CHA/GC-NPs did not significantly increase the release of protein and the activities of LDH, indicating that the nanoparticles did not cause any membrane damage to the intestine. These findings suggested that 5β-CHA/GC-NPs were safe and useful carriers for enhancing the absorption of the drug with poor absorption by intestinal membranes.
This paper references
10.1016/S0168-3659(03)00160-3
Potentiality of double liposomes containing salmon calcitonin as an oral dosage form.
Kenji Yamabe (2003)
Mucoadhesive liposomes coated with chitosan or carbopol for oral administration of peptide drugs
H Takeuchi (1999)
10.1021/JS960182O
Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers.
T. Aspden (1997)
10.1016/j.ijpharm.2013.02.024
Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
Zeting Yuan (2013)
10.1016/j.jconrel.2014.05.009
Self-assembled glycol chitosan nanoparticles for disease-specific theranostics.
J. Y. Yhee (2014)
10.3109/03639045.2015.1044904
Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration
J. Hecq (2015)
10.1021/LA0350608
Physicochemical Characteristics of Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing 5β-Cholanic Acid
Seunglee Kwon (2003)
10.1021/BM034094R
Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability.
J. Park (2003)
10.1016/J.JCONREL.2003.12.020
Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery.
J. Park (2004)
10.1016/J.CARBPOL.2007.06.016
Absorption and distribution of chitosan in mice after oral administration
L. Zeng (2008)
10.1016/J.JCONREL.2005.12.013
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
J. Kim (2006)
Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.
V. Lee (1991)
10.1016/j.jconrel.2013.08.297
Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Heebeom Koo (2013)
10.1016/j.jconrel.2010.01.021
Use of glycol chitosan modified by 5beta-cholanic acid nanoparticles for the sustained release of proteins during murine embryonic limb skeletogenesis.
T. Li (2010)
10.1016/0378-5173(92)90353-4
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
C. Lehr (1992)
10.1016/j.jconrel.2008.03.019
A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides.
Kyeongsoon Park (2008)
10.18433/J3CK88
Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug.
M. Arafat (2017)
10.1016/J.JCONREL.2005.12.015
Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.
C. Prego (2006)
10.1016/S0168-3659(00)00361-8
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
H. Mao (2001)
10.1021/ACS.MOLPHARMACEUT.6B00691
Improving Efficacy, Oral Bioavailability, and Delivery of Paclitaxel Using Protein-Grafted Solid Lipid Nanoparticles.
D. Pooja (2016)
10.2147/IJN.S122357
Low molecular weight chitosan-coated silver nanoparticles are effective for the treatment of MRSA-infected wounds
Yinbo Peng (2017)
10.1016/j.jconrel.2011.03.027
Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy.
S. J. Lee (2011)
10.1016/J.IJPHARM.2007.07.038
PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution.
Farnaz Esmaeili (2008)
10.1016/J.JCONREL.2005.05.017
Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats.
G. Fetih (2005)
10.3109/10837450.2014.915570
An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
A. Mooranian (2015)
10.1023/A:1011032328064
Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
A. Lamprecht (2004)
10.1002/JPS.20399
Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles.
Y. Zheng (2006)
10.1016/j.ijpharm.2017.11.034
The efficiency and mechanism of N-octyl-O, N-carboxymethyl chitosan-based micelles to enhance the oral absorption of silybin.
Tingjie Yin (2018)
10.1021/mp200572t
Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations.
K. Sonaje (2012)
10.1016/S0169-409X(00)00123-X
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
10.1007/s12272-001-1247-9
Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats
Hyung Gon Jo (2008)
10.1007/s13346-017-0373-8
Improved intestinal absorption of water-soluble drugs by acetylation of G2 PAMAM dendrimer nanocomplexes in rat
Chengyun Yan (2017)
10.1016/j.biomaterials.2007.12.038
Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.
Jongho Kim (2008)
10.1016/j.addr.2016.04.001
Lipid-based nanocarriers for oral peptide delivery.
Zhigao Niu (2016)
10.1016/S0169-409X(00)00120-4
Mucoadhesive nanoparticulate systems for peptide drug delivery.
H. Takeuchi (2001)
10.2147/IJN.S116063
A novel nanoemulsion-based method to produce ultrasmall, water-dispersible nanoparticles from chitosan, surface modified with cell-penetrating peptide for oral delivery of proteins and peptides
Ghullam Reza Barbari (2017)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar